IDEAYA Biosciences Inc. (IDYA)
NASDAQ
Closed
Oct 23, 2026
Day's Range
34.5352 wk Range
26.81Overview - IDYA - IDEAYA Biosciences Inc.
Key Statistics
Valuation
Enterprise Value
2.54B
P/E (Trailing)
-27.10
P/E (Forward)
-8.45
PEG Ratio
-0.70
Price / Sales (TTM)
14.30
Price / Book
2.79
EV / EBITDA
-11.90
Profitability
Profit Margin
-74.75%
Operating Margin
-1,380.72%
Return on Assets
-11.53%
Return on Equity
-16.21%
Ownership
Shares Outstanding
96.37M
Float
90.63M
Short % of Shares Outstanding
11.05%
Held by Insiders
2.19%
Held by Institutions
107.77%
Price stats
Beta
-0.03
50-Day Avg
37.71
200-Day Avg
34.11
Analyst Consensus
16 analysts
Average price target
$ 52.15Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - IDYA - IDEAYA Biosciences Inc.
Peers - IDYA - IDEAYA Biosciences Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- IDYANASDAQIDEAYA Biosciences Inc.3.34BMarket Cap+6.74%52-week change-27.11P/E (Trailing)-74.75%Profit Margin
- ARGXNASDAQArgenx SE54.66BMarket Cap+4.54%52-week change30.26P/E (Trailing)31.73%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.97BMarket Cap-110.32%52-week change37.78P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - IDYA - IDEAYA Biosciences Inc.
About
IDEAYA Biosciences Inc. is a precision medicine oncology company focused on discovering and developing targeted therapies for cancers defined by specific genetic alterations and biomarker profiles. The company combines small-molecule drug discovery, structural biology, bioinformatics, and translational biomarker…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
